"The treatment groups showed no difference, compared with the placebo group, for the ACR20, ACR50, and ACR70 measurements, but for two other measures, the Health Assessment Questionnaire and the 28-joint Disease Activity Score, the results showed trends toward dose-related improvements following MPC treatment."
You need to be very, very careful about reading too much into trends associated with self assesment questionaires not in keeping with observed results.
It really doesn't constitute "strong" evidence. If its "evidence" at all its in the "hearsay" category.
Those are "kinds of evidence", Your Honor...
- Forums
- ASX - By Stock
- MSB
- Maxim Research - New York
Maxim Research - New York, page-21
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.020(1.45%) |
Mkt cap ! $1.592B |
Open | High | Low | Value | Volume |
$1.40 | $1.41 | $1.38 | $1.585M | 1.134M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 7754 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 9488 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7754 | 1.395 |
14 | 114520 | 1.390 |
14 | 132434 | 1.385 |
18 | 196290 | 1.380 |
11 | 156301 | 1.375 |
Price($) | Vol. | No. |
---|---|---|
1.400 | 9488 | 8 |
1.405 | 61692 | 10 |
1.410 | 154626 | 13 |
1.415 | 51407 | 8 |
1.420 | 129928 | 5 |
Last trade - 11.58am 17/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online